SCHEMBL26325460

SCHEMBL26325460

CC(=O)/C(=N/OS(C)(=O)=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
GAA P10253 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 1/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
ALDH1A1 P00352 4/20 0.37
CYP3A4 P08684 1/20 0.37
PTGS2 P35354 1/20 0.37
MAPT P10636 2/20 0.36
ELANE P08246 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
HSD17B10 Q99714 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6024791 0.88 GAA (0.39) CES2CES1GAACYP2C19TSHR
SCHEMBL6024796 0.88 GAA (0.39) CES2CES1GAACYP2C19TSHR
SCHEMBL12629321 0.86 CES2 (0.43) CES2CES1GAACYP2C19TSHR
SCHEMBL6025557 0.83 TSHR (0.43) CES2CES1GAACYP2C19TSHR
SCHEMBL26325442 0.83 TSHR (0.43) CES2CES1GAACYP2C19TSHR
SCHEMBL6024818 0.83 TSHR (0.43) CES2CES1GAACYP2C19TSHR
SCHEMBL12329007 0.83 KDM4E (0.49) CES2CES1LMNAMAPK1HTT
SCHEMBL10182710 0.79 CES2 (0.47) CES2CES1TSHRLMNAL3MBTL1
SCHEMBL6025570 0.79 ALDH1A1 (0.42) LMNAL3MBTL1HTTALDH1A1MAPT
SCHEMBL7651351 0.78 CES1 (0.48) CES2CES1GAACYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 CES2 279/4885CES1 4009/4885GAA 3549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.